Simplex Trading’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-8,500
| Closed | -$10.9K | – | 9647 |
|
|
2025
Q4 | $10.9K | Sell |
8,500
-9,400
| -53% | -$12.6K | ﹤0.01% | 6932 |
|
|
2025
Q3 | $23K | Buy |
17,900
+800
| +5% | +$1.05K | ﹤0.01% | 7219 |
|
|
2025
Q2 | $20K | Buy |
+17,100
| New | +$19K | ﹤0.01% | 6766 |
|
|
2024
Q4 | – | Sell |
-4,400
| Closed | -$8K | – | 9115 |
|
|
2024
Q3 | $8K | Sell |
4,400
-85,500
| -95% | -$167K | ﹤0.01% | 7335 |
|
|
2024
Q2 | $159K | Sell |
89,900
-227,100
| -72% | -$555K | ﹤0.01% | 4871 |
|
|
2024
Q1 | $859K | Buy |
+317,000
| New | +$765K | ﹤0.01% | 3284 |
|
|
2023
Q4 | – | Sell |
-8,300
| Closed | -$24K | – | 9362 |
|
|
2023
Q3 | $24K | Buy |
8,300
+4,300
| +108% | +$11.2K | ﹤0.01% | 6471 |
|
|
2023
Q2 | $7K | Buy |
+4,000
| New | +$7.89K | ﹤0.01% | 7688 |
|
|
2022
Q3 | – | Sell |
-6,900
| Closed | -$11K | – | 10436 |
|
|
2022
Q2 | $11K | Buy |
6,900
+3,900
| +130% | +$9.65K | ﹤0.01% | 8202 |
|
|
2022
Q1 | $1K | Sell |
3,000
-51,100
| -94% | -$176K | ﹤0.01% | 10097 |
|
|
2021
Q4 | $212K | Buy |
54,100
+31,600
| +140% | +$148K | ﹤0.01% | 5108 |
|
|
2021
Q3 | $137K | Hold |
22,500
| – | – | ﹤0.01% | 6165 |
|
|
2021
Q2 | $138K | Buy |
22,500
+21,941
| +3,925% | +$117K | ﹤0.01% | 6261 |
|
|
2021
Q1 | $252K | Sell |
559
-777
| -58% | -$4.27K | ﹤0.01% | 4383 |
|
|
2020
Q4 | $801K | Buy |
1,336
+210
| +19% | +$1.38K | ﹤0.01% | 2833 |
|
|
2020
Q3 | $836K | Buy |
1,126
+744
| +195% | +$5.14K | ﹤0.01% | 2435 |
|
|
2020
Q2 | $153K | Buy |
382
+243
| +175% | +$846 | ﹤0.01% | 4302 |
|
|
2020
Q1 | $35K | Buy |
+139
| New | +$457 | ﹤0.01% | 5488 |
|
|
2019
Q4 | – | Sell |
-11
| Closed | -$5K | – | 7634 |
|
|
2019
Q3 | $5K | Buy |
+11
| New | +$87 | ﹤0.01% | 6611 |
|
|
2019
Q2 | – | Sell |
-21
| Closed | -$27K | – | 7465 |
|
|
2019
Q1 | $27K | Sell |
21
-9
| -30% | -$95 | ﹤0.01% | 5494 |
|
|
2018
Q4 | $25K | Buy |
+30
| New | +$234 | ﹤0.01% | 5160 |
|
|
2018
Q3 | – | Sell |
-86
| Closed | -$51K | – | 7740 |
|
|
2018
Q2 | $51K | Hold |
86
| – | – | ﹤0.01% | 5037 |
|
|
2018
Q1 | $8K | Buy |
+86
| New | +$565 | ﹤0.01% | 4225 |
|
|
2017
Q1 | – | Sell |
-10
| Closed | -$1K | – | 6466 |
|
|
2016
Q4 | $1K | Sell |
10
-22
| -69% | -$138 | ﹤0.01% | 5424 |
|
|
2016
Q3 | $1K | Hold |
32
| – | – | ﹤0.01% | 5351 |
|
|
2016
Q2 | $4K | Sell |
32
-24
| -43% | -$226 | ﹤0.01% | 4440 |
|
|
2016
Q1 | $2K | Buy |
+56
| New | +$404 | ﹤0.01% | 4739 |
|
|
2015
Q2 | – | Sell |
-16
| Closed | -$2K | – | 5523 |
|
|
2015
Q1 | $2K | Buy |
+16
| New | +$633 | ﹤0.01% | 4131 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Simplex Trading's LAB Position: Q1 2026 in Review
Simplex Trading opened a new position in Standard BioTools (LAB) in Q1 2026: 2,915 shares worth $2.68K. The stake represents ﹤0.01% of the portfolio and ranks #8252 among its holdings. This is a return to the name: Simplex Trading previously reported a position in LAB as recently as Q1 2025.
Simplex Trading first reported a position in LAB in Q4 2014 and has held it in 32 quarters since. The position peaked at $221K in Q3 2020. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Simplex Trading held 2,915 shares of Standard BioTools worth $2.68K as of Q1 2026.
- Standard BioTools was a new Simplex Trading position in Q1 2026.
- Standard BioTools made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8252 holding.
- Simplex Trading first reported a position in Standard BioTools in Q4 2014 and has held it in 32 quarters since.
- Simplex Trading's Standard BioTools position peaked at $221K in Q3 2020.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.